{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:36:35Z","timestamp":1760297795295},"reference-count":36,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1254\/jphs.fp0070091","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T05:49:58Z","timestamp":1182404998000},"page":"167-175","source":"Crossref","is-referenced-by-count":10,"title":["Effects of a Novel Histone Deacetylase Inhibitor, N-(2-Aminophenyl) Benzamide, on a Reversible Hypertrophy Induced by Isoproterenol in In Situ Rat Hearts"],"prefix":"10.1254","volume":"104","author":[{"given":"Yutaka","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamato","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juichiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Nakajima-Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Uesato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Tachibana H, Takaki M, Lee S, Ito H, Yamaguchi H, Suga H. New mechanoenergetic evaluation of left ventricular contractility in in situ rat hearts. Am J Physiol Heart Circ Physiol. 1997;272:H2671&ndash;H2678.","DOI":"10.1152\/ajpheart.1997.272.6.H2671"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.2170\/jjphysiol.48.445"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2001.03512.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kitagawa Y, Yamashita D, Ito H, Takaki M. The reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts. Am J Physiol Heart Circ Physiol. 2004;287:H277&ndash;H285.","DOI":"10.1152\/ajpheart.00073.2004"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200410000-00012"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.2170\/jjphysiol.54.175"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-004-0268-y"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, et al. Left ventricular diastolic dysfunction in type II diabetes mellitus model rats. Am J Physiol Heart Circ Physiol. 2002;282:H138&ndash;H148.","DOI":"10.1152\/ajpheart.2002.282.1.H138"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ohga Y, Sakata S, Takenaka C, Abe T, Tsuji T, Taniguchi S, et al. Cardiac dysfunction in terms of left ventricular mechanical work and energetics in hypothyroid rats. Am J Physiol Heart Circ Physiol. 2002;283:H631&ndash;H641.","DOI":"10.1152\/ajpheart.00046.2002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hagihara H, Yoshikawa Y, Ohga Y, Takenaka C, Murata K, Taniguchi S, et al. Na<sup>+<\/sup>\/Ca<sup>2+<\/sup> exchange inhibition protects the rat heart from ischemic-reperfusion injury by blocking energy-wasting processes. Am J Physiol Heart Circ Physiol. 2005;288:H1699&ndash;H1707.","DOI":"10.1152\/ajpheart.01033.2004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yoshikawa Y, Hagihara H, Ohga Y, Nakajima-Takenaka C, Murata K, Taniguchi S, et al. Calpain inhibitor-1 protects the rat heart from ischemic-reperfusion injury: analysis by mechanical work and energetics. Am J Physiol Heart Circ Physiol. 2005;288:H1690&ndash;H1698.","DOI":"10.1152\/ajpheart.00666.2004"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(69)90131-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zierhut W, Zimmer HG. Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res. 1989;65:1417&ndash;1425.","DOI":"10.1161\/01.RES.65.5.1417"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Boluyt MO, Long X, Eschenhagen T, Mende U, Schmitz W, Crow MT, et al. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol Heart Circ Physiol. 1995;269:H638&ndash;H647.","DOI":"10.1152\/ajpheart.1995.269.2.H638"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, et al. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension. 1992;19:708&ndash;712.","DOI":"10.1161\/01.HYP.19.6.708"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5383.1690"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res. 1999;84:633&ndash;646.","DOI":"10.1161\/01.RES.84.6.633"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA, et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res. 2001;89:938&ndash;940.","DOI":"10.1161\/hh2301.100003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Leenen FH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol. 2001;281:H2410&ndash;H2416.","DOI":"10.1152\/ajpheart.2001.281.6.H2410"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Morisco C, Zebrowski DC, Vatner DE, Vatner SF, Sadoshima J. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. Mol Cell Cardiol. 2001;33:561&ndash;573.","DOI":"10.1006\/jmcc.2000.1332"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Metzger JM. HDAC lightens a heavy heart. Nat Med. 2002;8:1078&ndash;1079.","DOI":"10.1038\/nm1002-1078"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res. 2004;95:971&ndash;980.","DOI":"10.1161\/01.RES.0000147557.75257.ff"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.5080"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00861-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Nagaoka Y, Maeda T, Kawai Y, Nakashima D, Oikawa T, Shimoke K, et al. Synthesis and cancer antiproliferative activity of new histone deacetylase inhibitors: hydrophilic hydroxamates and 2-aminobenzamide-containing derivatives. Eur J Med Chem. 2006;41:697&ndash;708.","DOI":"10.1016\/j.ejmech.2006.02.002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Hamamori Y, Schneider MD. HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy. J Clin Invest. 2003;112:824&ndash;826.","DOI":"10.1172\/JCI19834"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kook H, Lepore JJ, Gitler AD, Lu MM, Yung WW-M, Mackoy J, et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest. 2003;112:863&ndash;871.","DOI":"10.1172\/JCI19137"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.24.10636-10649.2004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Mckinsey TA, Olson EN. Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet. 2004;20:206&ndash;213.","DOI":"10.1016\/j.tig.2004.02.002"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Davis FJ, Pillai JB, Gupta M, Gupta MP. Concurrent opposite effects of trichostatin-A, an inhibitor of histone deacetylases, on the expression of &alpha;-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. Am J Physiol Heart Circ Physiol. 2005;288:H1477&ndash;H1490.","DOI":"10.1152\/ajpheart.00789.2004"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Baan J, Aouw Jong TT, Kerkhof PLM, Moene RJ, Van Dijk AD, Van Der Velde ET, et al. Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res. 1981;15:328&ndash;334.","DOI":"10.1093\/cvr\/15.6.328"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Baan J, Van Der Velde ET, De Bruin HG, Smeenk GJ, Koops J, Van Dijk AD, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 1984;70:812&ndash;823.","DOI":"10.1161\/01.CIR.70.5.812"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ito H, Takaki M, Yamaguchi H, Tachibana H, Suga H. Left ventricular volumetric conductance catheter for rats. Am J Physiol Heart Circ Physiol. 1996;270:H1509&ndash;H1514.","DOI":"10.1152\/ajpheart.1996.270.4.H1509"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Suga H, Hayashi T, Suehiro S, Hisano R, Shirahata M, Ninomiya I. Equal oxygen consumption rates of isovolumic and ejecting contractions with equal systolic pressure-volume areas in canine left ventricle. Circ Res. 1981;49:1082&ndash;1091.","DOI":"10.1161\/01.RES.49.5.1082"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.2170\/jjphysiol.51.177"},{"issue":"28","key":"36","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","volume":"265","year":"1990","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T06:08:05Z","timestamp":1629007685000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/104\/2\/104_2_167\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.fp0070091","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}